Cardiovascular Risk Assessment in Antiretroviral-Naïve HIV Patients
Paolo Maggi(Università degli Studi di Enna Kore), Paolo Bonfanti(University of California San Diego), Francesco Perilli(Policlinico Universitario di Catania), Giuseppe Vittorio De Socio(University of Perugia), Elena Ricci(Mario Negri Institute for Pharmacological Research), F Ingrassia(Azienda Ospedaliera Ospedale Maggiore), Tiziana Quirino(Ospedale di Circolo di Busto Arsizio), Antonio Lillo(Policlinico Universitario di Catania), Aurora Gadaleta(University of Bari Aldo Moro)
Cited by 28
Related Papers
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels
|medRxiv|2020|234
Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program
|Clinical Infectious Diseases|2012|208